Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
Plos One
|
July 8, 2021
The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database
Pascal Johann, Dominic Lenz, Markus Ries
Plos One
|
January 7, 2016
Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis
Anette Lampert, Georg F Hoffmann, Markus Ries
Medicine
|
September 9, 2005
The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women
Surya Gupta, Markus Ries, Steven Kotsopoulos, et al.
Orphanet Journal of Rare Diseases
|
October 3, 2020
Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study
Frederik Hoffmann, Susanne Hoffmann, Kevin Kunzmann, et al.
Journal of the American Society of Nephrology : JASN
|
June 18, 2002
Cardiac involvement in Anderson-Fabry disease
Christoph Kampmann, Frank Baehner, Markus Ries, et al.
The Review of Scientific Instruments
|
January 1, 2022
Beam halo measurements for special bunches in a storage ring by using a coronagraph
Ji-Gwang Hwang, Gregor Schiwietz, Paul Goslawski, et al.
BMJ Open
|
July 18, 2018
Publication status of completed registered studies in paediatric appendicitis: a cross-sectional analysis
Thomas Breil, Michael Boettcher, Georg F Hoffmann, et al.
BMC Medical Ethics
|
March 16, 2020
Disease awareness or subtle product placement? Orphan diseases featured in the television series "House, M.D." - a cross-sectional analysis
Konstantin Mechler, Juliane Rausch, William K Mountford, et al.
The Oncologist
|
March 30, 2016
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis
Clemens Stockklausner, Anette Lampert, Georg F Hoffmann, et al.
Orphanet Journal of Rare Diseases
|
May 14, 2016
Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act
Thomas Lutz, Anette Lampert, Georg F Hoffmann, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
Plos One
|
July 8, 2021
The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database
Pascal Johann, Dominic Lenz, Markus Ries
Plos One
|
January 7, 2016
Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis
Anette Lampert, Georg F Hoffmann, Markus Ries
Medicine
|
September 9, 2005
The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women
Surya Gupta, Markus Ries, Steven Kotsopoulos, et al.
Orphanet Journal of Rare Diseases
|
October 3, 2020
Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study
Frederik Hoffmann, Susanne Hoffmann, Kevin Kunzmann, et al.
Journal of the American Society of Nephrology : JASN
|
June 18, 2002
Cardiac involvement in Anderson-Fabry disease
Christoph Kampmann, Frank Baehner, Markus Ries, et al.
The Review of Scientific Instruments
|
January 1, 2022
Beam halo measurements for special bunches in a storage ring by using a coronagraph
Ji-Gwang Hwang, Gregor Schiwietz, Paul Goslawski, et al.
BMJ Open
|
July 18, 2018
Publication status of completed registered studies in paediatric appendicitis: a cross-sectional analysis
Thomas Breil, Michael Boettcher, Georg F Hoffmann, et al.
BMC Medical Ethics
|
March 16, 2020
Disease awareness or subtle product placement? Orphan diseases featured in the television series "House, M.D." - a cross-sectional analysis
Konstantin Mechler, Juliane Rausch, William K Mountford, et al.
The Oncologist
|
March 30, 2016
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis
Clemens Stockklausner, Anette Lampert, Georg F Hoffmann, et al.
Orphanet Journal of Rare Diseases
|
May 14, 2016
Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act
Thomas Lutz, Anette Lampert, Georg F Hoffmann, et al.
Page
of 10